September 30, 2024
InscriptaA company using CRISPR technology, and machine learning to develop high-performing genetically engineered strains.
.jpg)
Within the robotics sector, most of the actuator offerings are rigid and expensive. These actuators are much less suitable for human-computer interaction than more organic and flexible actuators. Creating bio-inspired robotics is an emerging field, and already seeing tremendous growth. Most of the advancement is still within research circles and a select few companies at the forefront of the technology, such as Boston Dynamics. By focusing on actuators, Artimus Robotics has a good chance of breaking into the field in a major way and exploiting the untapped market.
A potential challenge for their actuators is for its auxiliary technology to catch up. Bio-inspired robotics is a field with much room to grow, but the potential uses are numerous and groundbreaking for the biotechnological industry. The technology is still very much reliant on research grants given how early it is, but with time to mature, it could become very profitable. As this field continues to expand in research and employment in the medical world, Artimus Robotics hedges itself as a highly enterprising start-up.
Given the growth of bio-inspired robotics and its potential to advance modern medicine, we think that Artimus Robot’s sophisticated technology is an exceptional contender for the needed mechanical hardware. So far they have received funding from the U.S. Department of Energy, Heroic Ventures, Hunt Technology Ventures, National Science Foundation, Colorado Office of Economic Development with their latest investment being nearly one million dollars. In addition, the company has generated 13 patents and has contracts with NASA and the U.S. Army, with over 30 corporate sponsors. We believe the future of the company to be highly auspicious and would expect to see impressive things from them.
While the technology of bio-inspired robotics is still very new, and there are many potential roadblocks, the companies at the forefront of the field are very promising given the market potential. With Artimus Robotics recently securing 955k from the National Science foundation, it is obvious that major players within the biotech research field are taking notice of the work being done there. With continued innovation, Artimus Robotics stands a chance to become a major forerunner in the field.
A company using CRISPR technology, and machine learning to develop high-performing genetically engineered strains.
This week, we spotlight Artimus Robotics, a leader in the field of biomimetic and biotechnological robotics. They provide a diverse range of actuators, haptic devices, and electronics, with their flagship product being contracting and expanding actuators. These actuators leverage flexible materials, liquid dielectrics, and electrostatic forces to greatly improve mechanical hardware capabilities.
